Atara Biotherapeutics, Inc. (36) | Uncategorized (3)
- Commercialization Agreement by and between Atara Biotherapeutics, Inc. and Pierre Fabre Medicament, dated October 2, 2021 (Filed With SEC on February 28, 2022)
- Amended and Restated 2018 Inducement Plan (Filed With SEC on November 9, 2020)
- Description of Securities (Filed With SEC on February 27, 2020)
